Jean-Marc DeKeyser

Jean-Marc DeKeyser

Auto-generated profile, based on publicly available information

Jean-Marc DeKeyser

Department of Pharmacology, Northwestern University Feinberg School of Medicine

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2023 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
CTChristopher H. Thompson
Christopher H. Thompson
FPFranck Potet
Franck Potet
TATatiana V. Abramova
Tatiana V. Abramova
JDJean-Marc DeKeyser
Jean-Marc DeKeyser
NGNora F. Ghabra
Nora F. Ghabra
AGAlfred L. George
Alfred L. George
Pathogenic variants in voltage-gated sodium (NaV) channel genes including SCN2A, encoding NaV1.2, are discovered frequently in neurodevelopmental disorders with or without epilepsy. SCN2A is also a high-confidence risk gene for autism spectrum disorder (ASD) and nonsyndromic intellectual disability (ID). Previous work to determine the functional consequences of SCN2A variants yielded a paradigm in which predominantly gain-of-function variants cause neonatal-onset epilepsy, whereas loss-of-function variants are associated with ASD and ID. However, this framework was derived from a limited number of studies conducted under heterogeneous experimental conditions, whereas most disease-associated SCN2A variants have not been functionally annotated. We determined the functional properties of SCN2A variants using automated patch-clamp recording to demonstrate the validity of this method and to examine whether a binary classification of variant dysfunction is evident in a larger cohort studied under uniform conditions. We studied 28 disease-associated variants and 4 common variants using two alternatively spliced isoforms of NaV1.2 expressed in HEK293T cells. Automated patch-clamp recording provided a valid high throughput method to ascertain detailed functional properties of NaV1.2 variants with concordant findings for variants that were previously studied using manual patch clamp. Many epilepsy-associated variants in our study exhibited complex patterns of gain- and loss-of-functions that are difficult to classify by a simple binary scheme. The higher throughput achievable with automated patch clamp enables study of variants with greater standardization of recording conditions, freedom from operator bias, and enhanced experimental rigor. This approach offers an enhanced ability to discern relationships between channel dysfunction and neurodevelopmental disorders.

6 July 2023 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MRMarisol Romero-Tejeda
Marisol Romero-Tejeda
HFHananeh Fonoudi
Hananeh Fonoudi
CWCarly J. Weddle
Carly J. Weddle
JDJean-Marc DeKeyser
Jean-Marc DeKeyser
BLBrian Lenny
Brian Lenny
PBPaul W. Burridge
Paul W. Burridge

1 September 2009 in International Journal of Plant Sciences
Verified
Journal Article
Closed access
BNBenjamin J. Nelson
Benjamin J. Nelson
KMKenneth J. Maas
Kenneth J. Maas
JDJean‐Marc L. Dekeyser
Jean‐Marc L. Dekeyser
JSJoel P. Stafstrom
Joel P. Stafstrom

13 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CVCarlos G. Vanoye
Carlos G. Vanoye
TATatiana V. Abramova
Tatiana V. Abramova
JDJean-Marc DeKeyser
Jean-Marc DeKeyser
NGNora F. Ghabra
Nora F. Ghabra
MOMadeleine Oudin
Madeleine Oudin
AGAlfred L. George
Alfred L. George
Pathogenic variants in SCN8A , which encodes the voltage-gated sodium (Na V ) channel Na V 1.6, are associated with neurodevelopmental disorders including epileptic encephalopathy. Previous approaches to determine SCN8A variant function may be confounded by the use of a neonatal-expressed alternatively spliced isoform of Na V 1.6 (Na V 1.6N), and engineered mutations to render the channel tetrodotoxin (TTX) resistant. In this study, we investigated the impact of SCN8A alternative splicing on variant function by comparing the functional attributes of 15 variants expressed in two developmentally regulated splice isoforms (Na V 1.6N, Na V 1.6A). We employed automated patch clamp recording to enhance throughput, and developed a novel neuronal cell line (ND7/LoNav) with low levels of endogenous Na V current to obviate the need for TTX-resistance mutations. Expression of Na V 1.6N or Na V 1.6A in ND7/LoNav cells generated Na V currents that differed significantly in voltage-dependence of activation and inactivation. TTX-resistant versions of both isoforms exhibited significant functional differences compared to the corresponding wild-type (WT) channels. We demonstrated that many of the 15 disease-associated variants studied exhibited isoform-dependent functional effects, and that many of the studied SCN8A variants exhibited functional properties that were not easily classified as either gain- or loss-of-function. Our work illustrates the value of considering molecular and cellular context when investigating SCN8A variants.

26 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DHDalton J. Huey
Dalton J. Huey
EGEduardo Guadarrama
Eduardo Guadarrama
JDJean-Marc DeKeyser
Jean-Marc DeKeyser
CVCarlos G. Vanoye
Carlos G. Vanoye
CSChristine Q. Simmons
Christine Q. Simmons
AGAlfred L. George
Alfred L. George
Upstream open reading frames (uORFs) within the 5'-untranslated region (5'-UTR) of mRNA transcripts can regulate protein translation. Despite widespread prevalence within the human genome, they remain unidentified for many clinically relevant genes. A gene frequently associated with neonatal-onset epilepsy is KCNQ2, which encodes a neuronal voltage-gated potassium channel subunit that functions to dampen neuronal excitability. Heterozygous loss-of-function pathogenic KCNQ2 variants are known to cause a range of neurodevelopmental disorders and epileptic encephalopathies, but there remains an unmet clinical need for patients harboring these variants. We identified a single uORF in KCNQ2 that is highly repressive of protein translation and demonstrated that mutations disabling the uORF start codon enhance translation of encoded potassium channels. Additionally, we show that adenine base editing of the uORF start codon can weaken ribosome engagement at the uORF and enhance translation of the protein in a neuron-like cell line. This study establishes a previously underexplored regulatory feature for KCNQ2 and highlights the importance of understanding uORFs for clinically relevant genes, both for assessing disease risk and therapeutic potential.

15 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MRMarisol Romero-Tejeda
Marisol Romero-Tejeda
HFHananeh Fonoudi
Hananeh Fonoudi
CWCarly J. Weddle
Carly J. Weddle
JDJean-Marc DeKeyser
Jean-Marc DeKeyser
BLBrian Lenny
Brian Lenny
PBPaul W. Burridge
Paul W. Burridge
The reprogramming of somatic cells to a spontaneously contracting cardiomyocyte-like state using defined transcription factors has proven successful in mouse fibroblasts. However, this process has been less successful in human cells, thus limiting the potential clinical applicability of this technology in regenerative medicine. We hypothesized that this issue is due to a lack of cross-species concordance between the required transcription factor combinations for mouse and human cells. To address this issue, we identified novel transcription factor candidates to induce cell conversion between human fibroblasts and cardiomyocytes, using the network-based algorithm Mogrify. We developed an automated, high-throughput method for screening transcription factor, small molecule, and growth factor combinations, utilizing acoustic liquid handling and high-content kinetic imaging cytometry. Using this high-throughput platform, we screened the effect of 4,960 unique transcription factor combinations on direct conversion of 24 patient-specific primary human cardiac fibroblast samples to cardiomyocytes. Our screen revealed the combination of MYOCD , SMAD6 , and TBX20 (MST) as the most successful direct reprogramming combination, which consistently produced up to 40% TNNT2 + cells in just 25 days. Addition of FGF2 and XAV939 to the MST cocktail resulted in reprogrammed cells with spontaneous contraction and cardiomyocyte-like calcium transients. Gene expression profiling of the reprogrammed cells also revealed the expression of cardiomyocyte associated genes. Together, these findings indicate that cardiac direct reprogramming in human cells can be achieved at similar levels to those attained in mouse fibroblasts. This progress represents a step forward towards the clinical application of the cardiac direct reprogramming approach. GRAPHICAL HIGHLIGHTS: Using network-based algorithm Mogrify, acoustic liquid handling, and high-content kinetic imaging cytometry we screened the effect of 4,960 unique transcription factor combinations. Using 24 patient-specific human fibroblast samples we identified the combination of MYOCD , SMAD6 , and TBX20 (MST) as the most successful direct reprogramming combination. MST cocktail results in reprogrammed cells with spontaneous contraction, cardiomyocyte-like calcium transients, and expression of cardiomyocyte associated genes.